Lyell Immunopharma (LYEL) Other financing activities (2020 - 2026)

Lyell Immunopharma (LYEL) posted Other financing activities of $26000.0 for Q1 2026, down 85.64% sequentially from $181000.0 in Q4 2025.

Lyell Immunopharma (LYEL) Other financing activities (2020 - 2026) Analysis & Trends

Lyell Immunopharma has reported Other financing activities for 7 years, with the latest figure at $26000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $391000.0 (down 65.85% YoY) and the FY2025 annual result came in at $365000.0, down 70.75% from the prior year.
  • Other financing activities declined to $26000.0 in Q1 2026 per LYEL's latest filing, from $181000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $8.7 million in Q4 2022 and troughed at -$3.2 million in Q3 2022.
  • A 5-year average of $823000.0 and a median of $182500.0 in 2025 frame the typical range for Other financing activities.
  • The sharpest annual moves came in 2022 and 2024: Other financing activities plunged 712.1% in 2022, then jumped 623.84% in 2024.
  • Over 5 years, Other financing activities stood at $8.7 million in 2022, then plunged by 98.26% to $151000.0 in 2023, then surged by 623.84% to $1.1 million in 2024, then tumbled by 83.44% to $181000.0 in 2025, then plunged by 85.64% to $26000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $26000.0, $181000.0, and $184000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Lyell Immunopharma 326.39 Mn 326.39 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 496,000.00
Jun 30, 2026 496,000.00
Mar 31, 2026 26,000.00
Mar 31, 2026 26,000.00
Dec 31, 2025 181,000.00
Dec 31, 2025 181,000.00
Jun 30, 2025 184,000.00
Jun 30, 2025 184,000.00
Dec 31, 2024 1.09 Mn
Dec 31, 2024 1.09 Mn
Sep 30, 2024 -655,000.00
Sep 30, 2024 -655,000.00
Jun 30, 2024 707,000.00
Jun 30, 2024 707,000.00
Mar 31, 2024 103,000.00
Mar 31, 2024 103,000.00
Dec 31, 2023 151,000.00
Dec 31, 2023 151,000.00
Sep 30, 2023 -1.01 Mn
Sep 30, 2023 -1.01 Mn